Biotech Company Nucleai Raises $33M Series B to Expand Its Reach

Biotech Company Nucleai Raises $33M Series B to Expand Its Reach Nucleai, an AI-powered spatial biology company, has announced the closure of a $33 million Series B financing round co-led by Section 32 and Sanofi Ventures. This round brings Nucleai’s total funding to close to $50 million. Pharmaceutical companies use Nucleai’s platform for retrospective and prospective patient stratification analysis in clinical trials. It works to help drug development teams discover novel biomarkers, predict patient response, identify new targets and develop …